常见恶性肿瘤分子分期、分子分型研究进展
Research in molecular staging and categorizing of malignant tumors
摘要
人类生物医学进入分子水平 ,沿用至今的恶性肿瘤TNM分期已显示出其局限性。分子分期、分子分型是在原来TNM分期基础上 ,把分子生物学的最新研究成果结合到分期中 ,为肿瘤的预后和治疗决策提供更有利的证据。现主要介绍常见恶性肿瘤如乳腺癌、肺癌、结肠癌、恶性淋巴瘤等近年国外在这一领域的研究进展 ,同时介绍分子分期。
出处
《国外医学(肿瘤学分册)》
2003年第5期333-336,共4页
Foreign Medical Sciences (Cancer Section)
参考文献19
-
1Takahashi M, Rhodes DR, Furge KA, et al. Gene expression profiling of clear cell renal cell carcinoma: Gene identification and prognostic classification[J]. Proc Natl Acad Sci USA, 2001, 98(17):9754-9759.
-
2Peley G, Toth J, Csuka, et al. Imrnunohistochemistry and reverse transcriptase polyrnerase chain reaction on sentinel lymph nodes can improve the accuracy of nodal staging in breast cancer patients[J]. Int J Biol Markers. 2001, 16(4) : 227-232.
-
3Aparieio SA, Caldas C, Ponder B. Does massively parallel transcriptome analysis signify the end of cancer histopathology as we know it [J]. Genome Biol, 2000, 1(3): REVIEWS1021.
-
4Yan PS, Perry MR, Laux DE, et al. CpG island array an application toward deciphering epigenetic signatures of breast cancer [ J ]. Clin Cancer Res, 2000, 6(4) : 1432-1438.
-
5Jones C, Nonni AV, Fulford L, et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation[J]. BrJ Cancer, 2001, 85(3): 422-427.
-
6Porter DA, Krop IE, Nasser S, et al. A SAGE (serial analysis of gene expression) view of breast tumor prcgression[J]. Cancer Res, 2001, 61(15): 5697-5702.
-
7Beech DJ, Parekh N, Pang Y. Insulin-like growth factor-Ⅰ receptor antagonism results in increased cytotoxieity of breast eaneer cells to doxorubiein and taxol[J]. Oneol Rep, 2001, 8(2): 325-329.
-
8Nass SJ, Herman JG, Gabrielson E, et al. Aberrant methylation of the estrogen receptor and E-caderin 5'CpG islands increases with malignant progression in human breast cancer[J ]. Cancer Res, 2000, 60(16) : 4346-4368.
-
9Ishida M, Kitamura K, Kinoshita J, et al. Detection of micrometastasis in the sentinel lymph nodes in breast cancer[J]. Surgery, 2002,131 (1Suppl) : S211-216.
-
10Taback B, Chan AD, Kuo CT, et al. Detection of occult metastatic breast cancer cells in blood by a multirnolecular marker assay: Correlation with clinical stage of disease[J ]. Cancer Res, 2001, 61 (24) :8845-8850.
-
1周足力,杨帆,姜冠潮,黄宇清,付静,王俊.非小细胞肺癌组织中表皮生长因子受体与磷酸化Akt蛋白的表达及其意义[J].中华医学杂志,2008,88(15):1062-1065. 被引量:3
-
2于志勇,左文述,吴泰璜.肿瘤分子分期的应用前景[J].肿瘤防治杂志,2003,10(10):1107-1109.
-
3王云喜,孙玉鹗.非小细胞肺癌淋巴结的分子分期[J].中华外科杂志,2003,41(11):861-863. 被引量:3
-
4刘宜敏,林显敢,罗铭.血管内皮生长因子表达及微血管密度与鼻咽癌TNM分期的关系[J].肿瘤防治研究,2009,36(11):973-975. 被引量:4
-
5张百红,王湘辉.分子分期:肝癌分期的未来[J].现代肿瘤医学,2010,18(3):605-607. 被引量:4
-
6梁朝阳,刘慧峰,周乃康,母义明,柳曦,汪保安.LRP16基因在肺癌中的表达及其临床意义[J].解放军医学杂志,2008,33(5):598-599. 被引量:5
-
7吴志浩,周清华.肺癌分子诊断与分子分期研究进展[J].中国肺癌杂志,2008,11(1):34-39. 被引量:8
-
8曾薇,李惠武.肺癌微转移检测与分子分期的研究进展[J].临床肿瘤学杂志,2013,18(9):850-856. 被引量:5
-
9姚颐,宋启斌.肺癌分期的新进展[J].肿瘤学杂志,2009,15(6):481-485. 被引量:2
-
10王云喜,孙玉鹗,李向红,王湛博,刘元林,陈良安,张高魁.非小细胞肺癌患者淋巴结分子分期的临床病理研究[J].中华医学杂志,2007,87(3):161-164. 被引量:3